The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125895892 12589589 2 F 2015 20160803 20160725 20160823 EXP CA-HQ SPECIALTY-CA-2016INT000600 INTERCHEM 56.08 YR M Y 0.00000 20160823 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125895892 12589589 1 PS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Oral 20 MG, UNK 201749 20 MG
125895892 12589589 2 SS XELJANZ TOFACITINIB CITRATE 1 Oral 10 MG (5 MG,2 IN 1 D) Y 0 5 MG
125895892 12589589 3 SS XELJANZ TOFACITINIB CITRATE 1 Oral 10 MG(5 MG, 2 IN 1 D) Y 0 5 MG
125895892 12589589 4 SS XELJANZ TOFACITINIB CITRATE 1 Oral 10 MG, (5 MG, 2 IN 1 D) Y 0 5 MG
125895892 12589589 5 SS XELJANZ TOFACITINIB CITRATE 1 Oral 10 MG (5 MG,2 IN 1 D) Y 0 5 MG
125895892 12589589 6 SS CELEBREX CELECOXIB 1 Unknown 400 MG, (200 MG, 2 IN 1 D) Y 0 200 MG
125895892 12589589 7 SS CELEBREX CELECOXIB 1 Unknown AS NECESSARY Y 0
125895892 12589589 8 SS CELEBREX CELECOXIB 1 Oral (2 IN 1 D) Y 0
125895892 12589589 9 SS CELEBREX CELECOXIB 1 Oral ONCE PER DAY AND EVENTUALLY AS NEEDED Y 0
125895892 12589589 10 SS CELEBREX CELECOXIB 1 Oral (2 IN 1 D) Y 0
125895892 12589589 11 SS CELEBREX CELECOXIB 1 Oral (1 IN 1 D) Y 0
125895892 12589589 12 SS CELEBREX CELECOXIB 1 Oral 200 MG (200 MG,1 IN 1 D) Y 0 200 MG
125895892 12589589 13 SS CELEBREX CELECOXIB 1 Oral 200 MG (200 MG,1 IN 1 D) Y 0 200 MG
125895892 12589589 14 SS PLAQUENIL /00072602/ HYDROXYCHLOROQUINE DIPHOSPHATE 1 Unknown (200 MG, 1 D) Y 0 200 MG
125895892 12589589 15 SS PREDNISONE. PREDNISONE 1 (2.5 MG, 1 D) Y 0 2.5 MG
125895892 12589589 16 SS PREDNISONE. PREDNISONE 1 1.25 MG (2.5 MG, 1 IN 2 D) Y 0 2.5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125895892 12589589 1 Rheumatoid arthritis
125895892 12589589 2 Rheumatoid arthritis
125895892 12589589 6 Rheumatoid arthritis
125895892 12589589 7 Pain
125895892 12589589 14 Rheumatoid arthritis
125895892 12589589 15 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
125895892 12589589 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125895892 12589589 Abdominal pain upper
125895892 12589589 Constipation
125895892 12589589 Fall
125895892 12589589 Rheumatoid arthritis
125895892 12589589 Viral upper respiratory tract infection
125895892 12589589 Wrist fracture

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125895892 12589589 1 20150220 0
125895892 12589589 2 20150716 201512 0
125895892 12589589 3 201604 0
125895892 12589589 4 201604 20160803 0
125895892 12589589 5 20160806 20160808 0
125895892 12589589 11 20160223 0
125895892 12589589 12 20160327 0
125895892 12589589 13 20160328 0
125895892 12589589 14 20150220 20151016 0
125895892 12589589 16 20150904 0